Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Lineage Cell Therapeutics, Inc. LCTX

Full chart Compare
Set alert

Price alert · LCTX

All alert types
1.03 USD +0.02 (+1.98%)

At closeNov 4, 2026, 4:02 PM EST

1.03 0.00 0.00%

After hours · Nov 4, 4:02 PM ET

1.01 Day range 1.07
0.88 52-week range 1.99
YTD
-38.32%
1 year
-42.78%

Financial health

Altman Z-Score

-3.43 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

3 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C-1 / 5 overall

  • DCF 1
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 4
  • P/E 1
  • P/B 1

Valuation

P/E -6.0×
FY 2016: 10.3×FY 2017: -12.6×FY 2018: -2.5×FY 2019: -10.9×FY 2020: -12.6×FY 2021: -9.4×FY 2022: -7.8×FY 2023: -9.1×FY 2024: -5.4×FY 2025: -6.0×
FY 2016 5y median -7.8× FY 2025
P/S 26.4×
FY 2016: 156×FY 2017: 137×FY 2018: 81.6×FY 2019: 87.6×FY 2020: 342×FY 2021: 103×FY 2022: 13.5×FY 2023: 21.0×FY 2024: 10.6×FY 2025: 26.4×
FY 2016 5y median 21.0× FY 2025
P/B 8.6×
FY 2016: 3.0×FY 2017: 1.5×FY 2018: 1.2×FY 2019: 1.1×FY 2020: 2.7×FY 2021: 4.4×FY 2022: 2.7×FY 2023: 3.0×FY 2024: 1.3×FY 2025: 8.6×
FY 2016 5y median 3.0× FY 2025
P/FCF -19.8×
FY 2016: -7.8×FY 2017: -7.7×FY 2018: -3.4×FY 2019: -4.0×FY 2020: -13.3×FY 2021: -16.9×FY 2022: 308×FY 2023: -6.4×FY 2024: -4.3×FY 2025: -19.8×
FY 2016 5y median -6.4× FY 2025
EV/EBITDA -5.1×
FY 2016: -6.1×FY 2017: -5.6×FY 2018: -2.5×FY 2019: -3.5×FY 2020: -9.6×FY 2021: -8.3×FY 2022: -7.6×FY 2023: -6.9×FY 2024: -3.2×FY 2025: -5.1×
FY 2016 5y median -6.9× FY 2025
EV/Sales 23.8×
FY 2016: 148×FY 2017: 118×FY 2018: 66.5×FY 2019: 84.7×FY 2020: 304×FY 2021: 89.9×FY 2022: 13.0×FY 2023: 17.4×FY 2024: 6.0×FY 2025: 23.8×
FY 2016 5y median 17.4× FY 2025
FCF Yield -5.1%
FY 2016: -12.8%FY 2017: -12.9%FY 2018: -29.6%FY 2019: -25.0%FY 2020: -7.5%FY 2021: -5.9%FY 2022: 0.3%FY 2023: -15.5%FY 2024: -23.5%FY 2025: -5.1%
FY 2016 5y median -5.9% FY 2025

Profitability

Gross Margin 94.2%
FY 2016: 84.1%FY 2017: 90.6%FY 2018: 78.7%FY 2019: 72.1%FY 2020: 50.2%FY 2021: 63.4%FY 2022: 95.0%FY 2023: 92.5%FY 2024: 96.5%FY 2025: 94.2%
FY 2016 5y median 94.2% FY 2025
Operating Margin -149.6%
FY 2016: -2618.4%FY 2017: -2170.9%FY 2018: -2951.6%FY 2019: -2630.3%FY 2020: -3421.3%FY 2021: -1263.1%FY 2022: -153.2%FY 2023: -276.5%FY 2024: -226.1%FY 2025: -149.6%
FY 2016 5y median -226.1% FY 2025
Net Margin -436.5%
FY 2016: 1490.8%FY 2017: -1114.7%FY 2018: -3247.9%FY 2019: -792.2%FY 2020: -2671.3%FY 2021: -1104.2%FY 2022: -178.7%FY 2023: -240.2%FY 2024: -195.9%FY 2025: -436.5%
FY 2016 5y median -240.2% FY 2025
ROE -142.6%
FY 2016: 28.5%FY 2017: -12.3%FY 2018: -49.0%FY 2019: -10.4%FY 2020: -21.5%FY 2021: -46.6%FY 2022: -35.8%FY 2023: -33.9%FY 2024: -23.7%FY 2025: -142.6%
FY 2016 5y median -35.8% FY 2025
ROIC -19.7%
FY 2016: -43.7%FY 2017: -23.3%FY 2018: -43.6%FY 2019: -19.9%FY 2020: -24.6%FY 2021: -38.4%FY 2022: -21.3%FY 2023: -27.2%FY 2024: -21.4%FY 2025: -19.7%
FY 2016 5y median -21.4% FY 2025
ROA -56.4%
FY 2016: 23.5%FY 2017: -11.5%FY 2018: -45.2%FY 2019: -9.3%FY 2020: -19.1%FY 2021: -24.6%FY 2022: -21.2%FY 2023: -21.3%FY 2024: -16.4%FY 2025: -56.4%
FY 2016 5y median -21.3% FY 2025

Growth (YoY)

Revenue 53.2%
FY 2016: -11.1%FY 2017: -20.4%FY 2018: -21.0%FY 2019: 4.4%FY 2020: -47.7%FY 2021: 404.0%FY 2022: 277.4%FY 2023: -39.2%FY 2024: 6.2%FY 2025: 53.2%
FY 2016 FY 2025
Operating Income -1.4%
FY 2016: 10.4%FY 2017: 34.0%FY 2018: -7.4%FY 2019: 7.0%FY 2020: 32.0%FY 2021: -86.1%FY 2022: 54.2%FY 2023: -9.8%FY 2024: 13.2%FY 2025: -1.4%
FY 2016 FY 2025
EPS (diluted) -201.1%
FY 2016: 157.6%FY 2017: -150.0%FY 2018: -111.8%FY 2019: 77.4%FY 2020: -72.2%FY 2021: -85.7%FY 2022: 42.3%FY 2023: 20.0%FY 2024: 22.5%FY 2025: -201.1%
FY 2016 FY 2025
Free Cash Flow 17.8%
FY 2016: 10.1%FY 2017: 29.0%FY 2018: -7.3%FY 2019: 5.2%FY 2020: 38.8%FY 2021: -20.7%FY 2022: 102.7%FY 2023: -4626.3%FY 2024: 19.1%FY 2025: 17.8%
FY 2016 FY 2025

Financial Health

Current Ratio 5.2×
FY 2016: 2.9×FY 2017: 6.2×FY 2018: 5.3×FY 2019: 8.9×FY 2020: 5.7×FY 2021: 2.4×FY 2022: 3.2×FY 2023: 2.1×FY 2024: 3.6×FY 2025: 5.2×
FY 2016 5y median 3.2× FY 2025
Quick Ratio 5.2×
FY 2016: 2.9×FY 2017: 6.2×FY 2018: 5.3×FY 2019: 8.9×FY 2020: 5.7×FY 2021: 2.4×FY 2022: 3.2×FY 2023: 2.1×FY 2024: 3.6×FY 2025: 5.2×
FY 2016 5y median 3.2× FY 2025
Debt / Equity 0.1×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.1×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.1×
FY 2016 5y median 0.0× FY 2025
Net Debt / EBITDA 0.6×
FY 2016: 0.3×FY 2017: 0.9×FY 2018: 0.6×FY 2019: 0.1×FY 2020: 1.2×FY 2021: 1.2×FY 2022: 0.3×FY 2023: 1.4×FY 2024: 2.4×FY 2025: 0.6×
FY 2016 5y median 1.2× FY 2025
Interest Coverage 0.0×
FY 2016: -78.9×FY 2017: -56.2×FY 2018: -3.8×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 29.8%FY 2019: 0.1%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: -74.8%FY 2019: -1.6%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31